Application of Biodegradable Polymeric Materials in Interventional Medical Devices for Cardiovascular Therapy

doi:10.11908/j.issn.0253-374x.23278

Home > Archive>Volume 51, Issue 11, 2023 >1649-1656. DOI:10.11908/j.issn.0253-374x.23278

Application of Biodegradable Polymeric Materials in Interventional Medical Devices for Cardiovascular Therapy
DOI:
                        10.11908/j.issn.0253-374x.23278
                    
CSTR:
                        [cstr]
                    
Author:
                        WANG YunbingWANG Yunbing
National Engineering Research Center for Biomaterials， Sichuan University， Chengdu 610064， China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
GUO GaoyangGUO Gaoyang
National Engineering Research Center for Biomaterials， Sichuan University， Chengdu 610064， China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:National Engineering Research Center for Biomaterials， Sichuan University， Chengdu 610064， China
Clc Number:R318
Fund Project:

Article

Figures

Metrics

Reference [46]

Related [20]

Cited by

Materials

Comments

Abstract:

Degradable cardiovascular interventional devices have become a hot topic in medical device development. Biomedical materials are the core of degradable cardiovascular interventional devices. This paper summarizes the chemical and physical properties as well as the degradation characteristics of related degradable polymeric materials， and discusses the relationship between the expected functions of degradable cardiovascular interventional devices and the properties of degradable polymeric materials. Finally， it points the challenges and future development directions of biodegradable polymeric materials to provide reference for relevant practitioners.

Key words:biomedical materials;degradable polymers;cardiovascular interventional devices

Reference

[1] 马丽媛,王增武,樊静,等.《中国心血管健康与疾病报告2021》概要[J].中国介入心脏病学杂志, 2022, 7: 30.MA Liyuan, WANG Zengwu, FAN Jing, et al. The synopsis of “Annual Report on Cardiovascular Health and Diseases in China (2021)” [J]. Chinese Journal of Interventional Cardiology, 2022, 7: 30.

[2] WANG Y, LI G, YANG L, et al. Development of innovative biomaterials and devices for the treatment of cardiovascular diseases [J]. Advanced Materials, 2022, 34(46): 2201971.

[3] KURAMITSU S, OHYA M, SHINOZAKI T, et al. Risk factors and long-term clinical outcomes of second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry [J]. Circulation: Cardiovascular Interventions, 2019, 12(6): e007822.

[4] BISSESSOR N. Current perspectives in percutaneous atrial septal defect closure devices [J]. Medical Devices: Evidence and Research, 2015, 8: 297.

[5] OBIWELUOZOR F O, EMECHEBE G A, KIM D W, et al. Considerations in the development of small-diameter vascular graft as an alternative for bypass and reconstructive surgeries: a review [J]. Cardiovascular Engineering and Technology, 2020, 11: 495.

[6] MALIKMAMMADOV E, TANIR T E, KIZILTAY A, et al. PCL and PCL-based materials in biomedical applications [J]. Journal of Biomaterials Science( Polymer Edition), 2018, 29(7/9): 863.

[7] MIDDLETON J C, TIPTON A J. Synthetic biodegradable polymers as orthopedic devices [J]. Biomaterials, 2000, 21(23): 2335.

[8] SABINO M A, GONZáLEZ S, MáRQUEZ L, et al. Study of the hydrolytic degradation of polydioxanone PPDX [J]. Polymer Degradation and Stability, 2000, 69(2): 209.

[9] PARK J M , KIM D S, KIM S R. Nondestructive evaluation of interfacial damage properties for plasma-treated biodegradable poly (p-dioxanone) fiber/poly (L-lactide) composites by micromechanical test and surface wettability [J]. Composites Science and Technology, 2004, 64(6): 847.

[10] GARLOTTA D. A literature review of poly (lactic acid) [J]. Journal of Polymers and the Environment, 2001, 9: 63.

[11] GUPTA B, REVAGADE N, HILBORN J. Poly (lactic acid) fiber: an overview [J]. Progress in Polymer Science, 2007, 32(4): 455.

[12] NAIR L S, LAURENCIN C T. Biodegradable polymers as biomaterials [J]. Progress in Polymer Science, 2007, 32(8): 762.

[13] SABINO M, FEIJOO J, MüLLER A. Crystallisation and morphology of poly (p-dioxanone) [J]. Macromolecular Chemistry and Physics, 2000, 201(18): 2687.

[14] BAI W, CHEN D, LI Q, et al. In vitro hydrolytic degradation of poly (para-dioxanone) with high molecular weight [J]. Journal of Polymer Research, 2009, 16: 471.

[15] FENG Q, JIANG W, SUN K, et al. Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent [J]. Journal of Materials Science: Materials in Medicine, 2011, 22: 2319.

[16] MARTINS J A, LACH A A, MORRIS H L, et al. Polydioxanone implants: a systematic review on safety and performance in patients [J]. Journal of Biomaterials Applications, 2020, 34(7): 902.

[17] HOUDART R, LAVERGNE A, VALLEUR P, et al. Polydioxanone in digestive surgery: an experimental study [J]. The American Journal of Surgery, 1986, 152(3): 268.

[18] ESHRAGHI S, DAS S. Mechanical and microstructural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sintering [J]. Acta Biomaterialia, 2010, 6(7): 2467.

[19] ABEDALWAFA M, WANG F, WANG L, et al. Biodegradable poly-epsilon-caprolactone (PCL) for tissue engineering applications: a review [J]. Reviews on Advanced Materials Science, 2013, 34(2): 123.

[20] SHRIVASTAVA A, DONDAPATI S. Biodegradable composites based on biopolymers and natural bast fibres: a review [J]. Materials Today: Proceedings, 2021, 46: 1420.

[21] ASHAMMAKHI N, ROKKANEN P. Absorbable polyglycolide devices in trauma and bone surgery [J]. Biomaterials, 1997, 18(1): 3.

[22] ORMISTON J A, SERRUYS P W. Bioabsorbable coronary stents [J]. Circulation: Cardiovascular Interventions, 2009, 2(3): 255.

[23] SOMSZOR K, BAS O, KARIMI F, et al. Personalized, mechanically strong, and biodegradable coronary artery stents via melt electrowriting [J]. ACS Macro Letters, 2020, 9(12): 1732.

[24] WANG D, XU Y, LI Q, et al. Artificial small-diameter blood vessels: materials, fabrication, surface modification, mechanical properties, and bioactive functionalities [J]. Journal of Materials Chemistry B, 2020, 8(9): 1801.

[25] HOLZER R, HIJAZI Z M. Interventional approach to congenital heart disease [J]. Current Opinion in Cardiology, 2004, 19(2): 84.

[26] ROH J D, SAWH-MARTINEZ R, BRENNAN M P, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling [J]. Proceedings of the National Academy of Sciences, 2010, 107(10): 4669.

[27] HIBINO N, MEJIAS D, PIETRIS N, et al. The innate immune system contributes to tissue-engineered vascular graft performance [J]. The FASEB Journal, 2015, 29(6): 2431.

[28] MORENO K, MURRAY-WIJELATH J, YAGI M, et al. Circulating inflammatory cells are associated with vein graft stenosis [J]. Journal of Vascular Surgery, 2011, 54(4): 1124.

[29] GUPTA P, MANDAL B B. Tissue-engineered vascular grafts: emerging trends and technologies [J]. Advanced Functional Materials, 2021, 31(33): 2100027.

[30] SARKAR S, SALES K M, HAMILTON G, et al. Addressing thrombogenicity in vascular graft construction [J]. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2007, 82(1): 100.

[31] SáNCHEZ P F, BREY E M, BRICE?O J C. Endothelialization mechanisms in vascular grafts [J]. Journal of Tissue Engineering and Regenerative Medicine, 2018, 12(11): 2164.

[32] 杨立, 罗日方, 雷洋, 等. 微创介入全降解血管支架和心脏瓣膜国内外研发现状与研究前沿 [J]. 材料导报, 2019, 33(1): 40.YANG Li, LUO Rifang, LEI Yang, et al. Frontier research and development of minimally invasive and interventional fully biodegradable stent and heart valve [J]. Materials Reports, 2019, 33(1): 40.

[33] ZONG J, HE Q, LIU Y, et al. Advances in the development of biodegradable coronary stents: a translational perspective [J]. Materials Today Bio, 2022, 16: 100368.

[34] NIKLASON L E, LAWSON J H. Bioengineered human blood vessels [J]. Science, 2020, 370(6513): eaaw8682.

[35] DURáN-REY D, CRISóSTOMO V, SáNCHEZ-MARGALLO J A, et al. Systematic review of tissue-engineered vascular grafts [J]. Frontiers in Bioengineering and Biotechnology, 2021, 9: 771400.

[36] RADKE D, JIA W, SHARMA D, et al. Tissue engineering at the blood-contacting surface: a review of challenges and strategies in vascular graft development [J]. Advanced Healthcare Materials, 2018, 7(15): 1701461.

[37] KIRKTON R D, SANTIAGO-MAYSONET M, LAWSON J H, et al. Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation [J]. Science Translational Medicine, 2019, 11(485): eaau6934.

[38] CHANG W G, NIKLASON L E. A short discourse on vascular tissue engineering [J]. NPJ Regenerative Medicine, 2017, 2(1): 7.

[39] DAHL S L, KYPSON A P, LAWSON J H, et al. Readily available tissue-engineered vascular grafts [J]. Science Translational Medicine, 2011, 3(68): 68ra9.

[40] QUINT C, KONDO Y, MANSON R J, et al. Decellularized tissue-engineered blood vessel as an arterial conduit [J]. Proceedings of the National Academy of Sciences, 2011, 108(22): 9214.

[41] LAWSON J H, GLICKMAN M H, ILZECKI M, et al. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials [J]. The Lancet, 2016, 387(10032): 2026.

[42] LIN C, LIU L, LIU Y, et al. Recent developments in next-generation occlusion devices [J]. Acta Biomaterialia, 2021, 128: 100.

[43] SHI D, KANG Y, ZHANG G, et al. Biodegradable atrial septal defect occluders: a current review [J]. Acta Biomaterialia, 2019, 96: 68.

[44] LI Z, KONG P, LIU X, et al. A fully biodegradable polydioxanone occluder for ventricle septal defect closure [J]. Bioactive Materials, 2023, 24: 252.

[45] GUO G, HU J, WANG F, et al. A fully degradable transcatheter ventricular septal defect occluder: towards rapid occlusion and post-regeneration absorption [J]. Biomaterials, 2022, 291: 121909.

[46] LI B, XIE Z, WANG Q, et al. Biodegradable polymeric occluder for closure of atrial septal defect with interventional treatment of cardiovascular disease [J]. Biomaterials, 2021, 274: 120851.

Get Citation

WANG Yunbing, GUO Gaoyang. Application of Biodegradable Polymeric Materials in Interventional Medical Devices for Cardiovascular Therapy[J].同济大学学报(自然科学版),2023,51(11):1649~1656

Copy

Article Metrics

Abstract:307
PDF: 715
HTML: 834
Cited by: 0

History

Received:August 12,2023
Revised:
Adopted:
Online: December 01,2023
Published:

Get Citation

Share

Article Metrics

History

Article QR Code